Evidence map›Paper›PMID 30566231›Full record

ArticleTransfusion2019

Piloting and implementation of quality assessment and quality control procedures in RBC-Omics: a large multi-center study of red blood cell hemolysis during storage.

Mars Stone, Sheila M Keating, Tamir Kanias, Marion C Lanteri, Mila Lebedeva, Derek Sinchar, Dylan Hampton, Adam Jakub, Val Rychka, Greg Brewer and 13 more

Abstract read
PubMed Publisher
In one paragraph

Article in Transfusion, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 21 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Big Data in Transfusion Medicine and Artificial Intelligence Analysis for Red Blood Cell Quality Control.Transfusion medicine and hemotherapy : offizielles Organ der Deutschen Gesellschaft fur Transfusionsmedizin und Immunhamatologie · 2023
    Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

23 authors at 8 institutions in 2 countries.

Mars StoneVitalant Research Institute (Formerly Blood Systems Research Institute), San Francisco, California.ORCID 0000-0001-5619-2767
Sheila M KeatingVitalant Research Institute (Formerly Blood Systems Research Institute), San Francisco, California.
Tamir KaniasPittsburgh Heart, Lung, Blood and Vascular Medicine Institute, University of Pittsburgh, Pittsburgh, Pennsylvania.ORCID 0000-0001-6558-0913
Marion C LanteriVitalant Research Institute (Formerly Blood Systems Research Institute), San Francisco, California.
Mila LebedevaVitalant Research Institute (Formerly Blood Systems Research Institute), San Francisco, California.
Derek SincharPittsburgh Heart, Lung, Blood and Vascular Medicine Institute, University of Pittsburgh, Pittsburgh, Pennsylvania.
Dylan HamptonVitalant Research Institute (Formerly Blood Systems Research Institute), San Francisco, California.
Adam JakubPittsburgh Heart, Lung, Blood and Vascular Medicine Institute, University of Pittsburgh, Pittsburgh, Pennsylvania.
Val RychkaPittsburgh Heart, Lung, Blood and Vascular Medicine Institute, University of Pittsburgh, Pittsburgh, Pennsylvania.
Greg BrewerPittsburgh Heart, Lung, Blood and Vascular Medicine Institute, University of Pittsburgh, Pittsburgh, Pennsylvania.
Sonia BakkourVitalant Research Institute (Formerly Blood Systems Research Institute), San Francisco, California.
Nelly GefterVitalant Research Institute (Formerly Blood Systems Research Institute), San Francisco, California.
Karla MurciaVitalant Research Institute (Formerly Blood Systems Research Institute), San Francisco, California.
Grier P PageRTI International, Atlanta, Georgia.
Stacy Endres-DigheRTI International, Rockville, Maryland.
Walter BialkowskiBlood Research and Medical Sciences Institutes, Blood Center of Wisconsin, Milwaukee, Wisconsin.
Xiaoyun FuBloodworks NW Research Institute; and the Department of Laboratory Medicine and the Department of Medicine, Division of Hematology, University of Washington School of Medicine, Seattle, Washington.
Jim ZimringBloodworks NW Research Institute; and the Department of Laboratory Medicine and the Department of Medicine, Division of Hematology, University of Washington School of Medicine, Seattle, Washington.
Thomas J RaifeDepartment of Pathology and Laboratory Medicine, University of Wisconsin-Madison, Madison, Wisconsin.
Steve KleinmanClinical Pathology, University of British Columbia, School of Medicine, Vancouver, British Columbia, Canada.
Mark T GladwinPittsburgh Heart, Lung, Blood and Vascular Medicine Institute, University of Pittsburgh, Pittsburgh, Pennsylvania.
Michael P BuschVitalant Research Institute (Formerly Blood Systems Research Institute), San Francisco, California.
National Heart, Lung, and Blood Institute Recipient Epidemiology Donor Evaluation Study III (REDS-III) Program
University of Pittsburgh · USBlood Systems Research Institute · USUniversity of California, San Francisco · USRTI International · USUniversity of Washington · USUniversity of British Columbia · CAUniversity of Wisconsin–Madison · USVersiti Blood Center of Wisconsin · US

Funding

Storage Lesion in Banked Blood Due to Disruption of Nitric Oxide HomeostasisR01HL098032 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Mark T Gladwin · 2009 to 2026
$12.5M
NHLBI NIH HHS HHSN268201100001INHLBI NIH HHS HHSN268201100002INHLBI NIH HHS HHSN268201100004INHLBI NIH HHS HHSN268201100005INHLBI NIH HHS HHSN268201100007INHLBI NIH HHS HHSN268201100008INHLBI NIH HHS HHSN268201100009INHLBI NIH HHS R01 HL098032
6 · The paper itself

Abstract

backgroundThe major aims of the RBC-Omics study were to evaluate the genomic and metabolomic determinants of spontaneous and stress-induced hemolysis during RBC storage. This study was unique in scale and design to allow evaluation of RBC donations from a sufficient number of donors across the spectrum of race, ethnicity, sex, and donation intensity. Study procedures were carefully piloted, optimized, and controlled to enable high-quality data collection.

methodsThe enrollment goal of 14,000 RBC donors across four centers, with characterization of RBC hemolysis across two testing laboratories, required rigorous piloting and optimization and establishment of a quality assurance (QA) and quality control (QC) program. Optimization of WBC elution from leukoreduction (LR) filters, development and validation of small-volume transfer bags, impact of manufacturing and sample-handling procedures on hemolysis parameters, and testing consistency across laboratories and technicians and over time were part of this quality assurance/quality control program.

resultsLR filter elution procedures were optimized for obtaining DNA for analysis. Significant differences between standard and pediatric storage bags led to use of an alternative LR-RBC transfer bag. The impact of sample preparation and freezing methods on metabolomics analyses was evaluated. Proficiency testing monitored and documented testing consistency across laboratories and technicians.

conclusionPiloting and optimization, and establishment of a robust quality assurance/quality control program documented process consistency throughout the study and was essential in executing this large-scale multicenter study. This program supports the validity of the RBC-Omics study results and a sample repository that can be used in future studies.

Indexed as

Adenosine TriphosphateBlood PreservationErythrocytesHemolysisHumansQuality ControlAdenosine Triphosphate

Identifiers

PMID30566231
OpenAlexW2905136232

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.